Cardiovascular benefits Ozempic is approved by the FDA for reducing the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and established heart disease
Klinic manages this entirely for you
Patient assistance programs : Novo Nordisks patient assistance program (PAP) provides free Ozempic and Rybelsus to eligible individuals
Patients often note diminished appetite, increased satiety, and healthier food cravings
Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning